ArticlePloS one2020

CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation.

Bin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.